Altered expression of BRCA1, BRCA2, and a newly identified BRCA2 exon 12 deletion variant in malignant human ovarian, prostate, and breast cancer cell lines.
about
Profiling follicle stimulating hormone-induced gene expression changes in normal and malignant human ovarian surface epithelial cellsOverexpression of LASP-1 mediates migration and proliferation of human ovarian cancer cells and influences zyxin localisationLoss of BRCA1-A complex function in RAP80 null tumor cellsPaclitaxel resistance and multicellular spheroid formation are induced by kallikrein-related peptidase 4 in serous ovarian cancer cells in an ascites mimicking microenvironment.Suberoylanilide hydroxamic acid (SAHA) enhances olaparib activity by targeting homologous recombination DNA repair in ovarian cancer.BRCA1 alterations are associated with endometriosis, but BRCA2 alterations show no detectable endometriosis risk: a study in Indian population.Functional redundancy of exon 12 of BRCA2 revealed by a comprehensive analysis of the c.6853A>G (p.I2285V) variantId-I stimulates cell proliferation through activation of EGFR in ovarian cancer cellsSpecificity and prognostic validation of a polyclonal antibody to detect Six1 homeoprotein in ovarian cancerFamily history of prostate and breast cancer and the risk of prostate cancer in the PSA eraTargeted sequencing of BRCA1 and BRCA2 across a large unselected breast cancer cohort suggests that one-third of mutations are somaticOverexpression of the thymosin beta-10 gene in human ovarian cancer cells disrupts F-actin stress fiber and leads to apoptosis.Identification of a novel function of TWIST, a bHLH protein, in the development of acquired taxol resistance in human cancer cells.Loss of mismatch repair activity in simian virus 40 large T antigen-immortalized BPH-1 human prostatic epithelial cell line.
P2860
Q50432263-060DA246-0564-4F34-8EC2-FC94BA9D8582Q5206280-9FF0AB12-DF76-49CF-9261-BB870B6B2037Q54749306-3C9A44F7-7FA0-4D96-872E-71FF7F89C74BQ54831365-537EBB93-77AD-47BD-8199-CD9BAEF0C896Q54936981-8F779607-C6E9-4B78-81BC-88B1B59AE5CFQ54936983-7AF003C6-A32C-4BBB-A46D-17F895C985C0Q54936988-C6BBAF51-7C40-4EDE-AE73-12177D8C1ACAQ54936989-10B300D5-5283-4703-96F6-EAF0C4FB8C28Q54973170-91F9B94C-9ECC-4228-9367-F81637565805Q6459234-802CD4F6-C88F-4271-BD53-D61E5A2B1507Q7118483-87E3A996-ED8E-441B-9514-4719562C9B5B
P1343
Q28183254-C92DEF5F-0965-463A-8EF3-021DCF403032Q30159496-B0704688-3962-4761-AC67-CCE9487F2B7FQ34336205-7CA16FD1-A485-4B09-A4DA-147A2B63087DQ34602948-A26F3BC1-8351-42B7-8553-E273009FA504Q35141937-B2B92493-6250-4418-9932-93920F7475E2Q35160913-D5FDFA03-28A9-4C67-90D4-268865A7645EQ36408445-7C963D93-2354-43DA-8AB0-9E8B5DED2787Q36695270-CBCFECDA-C301-408B-AE7F-95BDC6C38705Q36714078-8A169BE1-3A24-451F-8F52-13960E3546BAQ36952992-C8C2B4F2-2498-4B36-ABE0-A0A5CC307F91Q37123931-B61BAC4D-915D-4344-A562-DAFFBC0AD150Q38293820-C18AE9DA-0778-43F1-8044-1510529A944CQ40599191-A3D194A2-6D3D-4CFE-B73C-B300CC7F3437Q40789174-B46BC742-A006-4A31-AE8A-80BDFE3CD976
P2860
Altered expression of BRCA1, BRCA2, and a newly identified BRCA2 exon 12 deletion variant in malignant human ovarian, prostate, and breast cancer cell lines.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Altered expression of BRCA1, B ...... and breast cancer cell lines.
@en
type
label
Altered expression of BRCA1, B ...... and breast cancer cell lines.
@en
prefLabel
Altered expression of BRCA1, B ...... and breast cancer cell lines.
@en
P2093
P2860
P4510
P1476
Altered expression of BRCA1, B ...... , and breast cancer cell lines
@en
P2093
P2860
P304
P356
10.1002/1098-2744(200008)28:4<236::AID-MC6>3.0.CO;2-H
P50
P577
2000-08-01T00:00:00Z